MX2010005597A - Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos. - Google Patents

Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.

Info

Publication number
MX2010005597A
MX2010005597A MX2010005597A MX2010005597A MX2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A MX 2010005597 A MX2010005597 A MX 2010005597A
Authority
MX
Mexico
Prior art keywords
compositions
peptide
immunoregulatory peptides
novel immunoregulatory
novel
Prior art date
Application number
MX2010005597A
Other languages
English (en)
Inventor
Vladislav Deigin
Original Assignee
Immunotech Dev Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech Dev Inc filed Critical Immunotech Dev Inc
Publication of MX2010005597A publication Critical patent/MX2010005597A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe un péptido biológicamente activo de formula (1) [X-L y Glu-trp-y], una composición farmacéutica novedosa que contiene el péptido, un método para preparar el péptido y usos del mismo.
MX2010005597A 2007-11-20 2008-11-20 Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos. MX2010005597A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98928007P 2007-11-20 2007-11-20
PCT/CA2008/002037 WO2009065217A1 (en) 2007-11-20 2008-11-20 Novel immunoregulatory peptides, compositions and uses thereof

Publications (1)

Publication Number Publication Date
MX2010005597A true MX2010005597A (es) 2010-10-25

Family

ID=40667077

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005597A MX2010005597A (es) 2007-11-20 2008-11-20 Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.

Country Status (9)

Country Link
US (1) US20110003751A1 (es)
JP (1) JP2011503215A (es)
AU (1) AU2008328485B2 (es)
BR (1) BRPI0820659A2 (es)
CA (1) CA2706525C (es)
IL (1) IL205843A0 (es)
MX (1) MX2010005597A (es)
WO (1) WO2009065217A1 (es)
ZA (1) ZA201006443B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2464379B1 (en) 2009-08-10 2014-07-30 Immunotech Developments Inc. Vaccine having a peptide adjuvant for eliciting a specific immune response to treat influenza viral infection
US20150011484A1 (en) * 2011-03-31 2015-01-08 Aptoex Technologies, Inc. Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan
EP3548137B1 (en) 2016-12-01 2020-11-04 Advanced Bionics AG Cochlear implants including electrode arrays and methods of making the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2107691C1 (ru) * 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
WO1997019691A1 (en) * 1995-11-28 1997-06-05 Wei, Edward, T. Gamma-l-glutamyl containing immunomodulator compounds and methods therewith
US6159940A (en) * 1996-02-28 2000-12-12 Immunotech Developments Inc. Method for modulating hemopoiesis

Also Published As

Publication number Publication date
BRPI0820659A2 (pt) 2019-09-24
AU2008328485B2 (en) 2013-03-28
IL205843A0 (en) 2010-11-30
WO2009065217A1 (en) 2009-05-28
JP2011503215A (ja) 2011-01-27
CA2706525C (en) 2012-05-01
US20110003751A1 (en) 2011-01-06
AU2008328485A1 (en) 2009-05-28
ZA201006443B (en) 2011-12-28
CA2706525A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
GB2431404A (en) Peptide
EP2583976A3 (en) Peptide vaccines with SEQ ID NO: 210, 196, 202, 213, 214, 214 or 223 for cancers expressing tumor-associated antigens
TW200800999A (en) Novel compounds
TW200616995A (en) Novel compounds
MX346822B (es) Pro-drogas de compuestos de 2,4-pirimidindiamina y sus usos.
TW200745084A (en) Novel compounds
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
UA100228C2 (uk) Фармацевтична композиція, яка містить тетрагідрофолієву кислоту
TW200738659A (en) Novel compounds
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
MY150497A (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
TW200605888A (en) Novel compounds
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
DE602004024213D1 (en) Aminopropanolderivate
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
ZA200807027B (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
MXPA05010613A (es) Formulacion parenteral de acido micofenolico, una sal o profarmaco del mismo.
MX2010005597A (es) Péptidos inmunoreguladores novedosos, composiciones y usos de los mismos.
UA104281C2 (ru) Противоопухолевые аналоги пептидов, способ их получения и фармацевтическая композиция на них основе
WO2007015918A3 (en) Novel biologically active peptides and their new uses
WO2005105832A3 (en) Biologically active peptide vapeehptllteaplnpk derivatives
MY139409A (en) Benzoxazine and quinoxaline and uses
WO2007044574A3 (en) Pharmaceutical compositions, methods of preparation thereof, and methods of treatment

Legal Events

Date Code Title Description
FG Grant or registration